Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Figure S5 from ANXA1 Binds and Stabilizes EGFR to Promote Nasopharyngeal Carcinoma Radioresistance

View through CrossRef
<p>Figure S5. Immunohistochemistry (IHC) showing the expression levels of ANXA1 and EGFR in the subcutaneous xenografts from HK1 nasopharyngeal carcinoma (NPC) cells with ANXA1 knockdown, HK1 NPC cells with ANXA1 knockdown and EGFR overexpression and shNC control HK1 cells</p>
Title: Figure S5 from ANXA1 Binds and Stabilizes EGFR to Promote Nasopharyngeal Carcinoma Radioresistance
Description:
<p>Figure S5.
Immunohistochemistry (IHC) showing the expression levels of ANXA1 and EGFR in the subcutaneous xenografts from HK1 nasopharyngeal carcinoma (NPC) cells with ANXA1 knockdown, HK1 NPC cells with ANXA1 knockdown and EGFR overexpression and shNC control HK1 cells</p>.

Related Results

Data from ANXA1 Binds and Stabilizes EGFR to Promote Nasopharyngeal Carcinoma Radioresistance
Data from ANXA1 Binds and Stabilizes EGFR to Promote Nasopharyngeal Carcinoma Radioresistance
<div>Abstract<p>Radioresistance is a serious obstacle to successful nasopharyngeal carcinoma (NPC) treatment. Annexin A1 (ANXA1) is associated with EGFR and is involved...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract Introduction Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
A meta-analysis of prognosis difference between adolescent and adult nasopharyngeal carcinoma
A meta-analysis of prognosis difference between adolescent and adult nasopharyngeal carcinoma
Review question / Objective: Clinical trials for young patients with nasopharyngeal carcinoma are very limited. because of the rarity of nasopharyngeal carcinoma in young patients,...
Plasma ctDNA biomarker study in patients with non-small cell lung cancer with EGFR exon 20 insertion mutation treated with sunvozertinib.
Plasma ctDNA biomarker study in patients with non-small cell lung cancer with EGFR exon 20 insertion mutation treated with sunvozertinib.
8563 Background: There are limited reports on biomarker studies of non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion mutation (exon...
Abstract 557: Noninvasive analysis of acquired resistance to EGFR-TKI
Abstract 557: Noninvasive analysis of acquired resistance to EGFR-TKI
Abstract BACKGROUND Epidermal growth factor receptor (EGFR) T790M mutation is associated with EGFR tyrosine kinase inhibitors (EGFR-TKIs) resistance i...
Correlation between CD133 and EGFR Expression with Grading of Ovarian Carcinoma
Correlation between CD133 and EGFR Expression with Grading of Ovarian Carcinoma
BackgroundOvarian carcinoma account for 90% of all malignant ovarian tumors. Epidermal Growth Factor Receptor (EGFR), also known asErbB1/HER1, has an important role in tumor cell p...

Back to Top